[
    [
        {
            "time": "2021-06-29",
            "original_text": "4家医药公司分红582亿！恒瑞攒钱研发，迈瑞慷慨，云南白药分近50亿，Biotech几乎不分！",
            "features": {
                "keywords": [
                    "医药公司",
                    "分红",
                    "恒瑞",
                    "迈瑞",
                    "云南白药",
                    "Biotech"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "4家医药公司分红582亿！恒瑞攒钱研发，迈瑞慷慨，云南白药分近50亿，Biotech几乎不分！",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-06-29",
            "original_text": "CXCR4抑制剂III期研究失败，复星医药拥有中国权益",
            "features": {
                "keywords": [
                    "CXCR4",
                    "抑制剂",
                    "III期研究",
                    "失败",
                    "复星医药"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "CXCR4抑制剂III期研究失败，复星医药拥有中国权益",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-06-29",
            "original_text": "沪港通十大成交活跃股排名（6月29日）",
            "features": {
                "keywords": [
                    "沪港通",
                    "成交活跃股",
                    "排名"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沪港通十大成交活跃股排名（6月29日）",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-29",
            "original_text": "抗癌龙头突然大跌14%，两大传闻突袭！连续下跌",
            "features": {
                "keywords": [
                    "抗癌",
                    "龙头",
                    "大跌",
                    "传闻",
                    "连续下跌"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "抗癌龙头突然大跌14%，两大传闻突袭！连续下跌",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-06-29",
            "original_text": "北向资金今日净卖出31.39亿元，贵州茅台获净买入额3.17亿元",
            "features": {
                "keywords": [
                    "北向资金",
                    "净卖出",
                    "贵州茅台",
                    "净买入"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "白酒"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "北向资金今日净卖出31.39亿元，贵州茅台获净买入额3.17亿元",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-06-29",
            "original_text": "医药生物行业周报：第五批集采结果发布 注射剂成为主力剂型",
            "features": {
                "keywords": [
                    "医药生物",
                    "集采",
                    "注射剂",
                    "主力剂型"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业周报：第五批集采结果发布 注射剂成为主力剂型",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-06-28",
            "original_text": "A股融资融券日报：两融余额增加94.84亿元（6月28日）",
            "features": {
                "keywords": [
                    "A股",
                    "融资融券",
                    "两融余额",
                    "增加"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股融资融券日报：两融余额增加94.84亿元（6月28日）",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-06-29",
            "original_text": "北向资金动向盘点：逢涨大额减持猪肉股",
            "features": {
                "keywords": [
                    "北向资金",
                    "减持",
                    "猪肉股"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "农业"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "北向资金动向盘点：逢涨大额减持猪肉股",
                "Correlation": 7,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-06-29",
            "original_text": "机构上调宁德时代目标价至600元，北向资金却大幅抛售3.91亿",
            "features": {
                "keywords": [
                    "宁德时代",
                    "目标价",
                    "上调",
                    "北向资金",
                    "抛售"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "新能源"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "机构上调宁德时代目标价至600元，北向资金却大幅抛售3.91亿",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]